Parkinson Disease Telerehabilitation Program (PDTR): a Home-motor Program. A Pilot Study.

Sponsor
Istituti Clinici Scientifici Maugeri SpA (Other)
Overall Status
Completed
CT.gov ID
NCT05762562
Collaborator
(none)
33
1
12.9
2.6

Study Details

Study Description

Brief Summary

Parkinson's disease (PD) leads to multifactorial disabilities with consequent social restrictions, especially in the COVID-19 era. Continuity of care, especially rehabilitation measures, is critical to improve or maintain an adequate QoL for patients. The Parkinson Disease Telerehabilitation Program (PDTR) is an individualized home rehabilitation program using open-source platforms (OSp).

The main purpose of this pilot study is to investigate the feasibility of TR in patients with PD by using free OS platforms (PDTR PROGRAM).

The target of this study was to have at least 90% of participants completing the program. To complete the program every single patient had to complete at least 80% of the prescribed TR sessions.

Condition or Disease Intervention/Treatment Phase
  • Other: Telerehabilitation with open source platforms

Detailed Description

Participants were PD patient afferent to the Neurology ambulatory. Patients underwent an initial evaluation (T0) by the neurologist and physiotherapist. During T0, also the level of digital literacy was evaluated

Participants included in the study were separated into three groups based on their residual motor skills evaluated by the Short Physical Performance Battery (SPPB).

Each group corresponded to a Program (Pr). SPPB score between 12 and 10: Pr. A for patients with capable motor skills; they were were associated to the TR program A (TrP.A).

SPPB score between 9 and 7: Pr. B for patients with reduced motor skills; they were were associated to the TR program B (TrP.B).

SPPB score lower than 7: Pr. C for patients who didn't show having sufficient motor skills; they were were associated to the telemonitoring program C (TmP.C) without any exercise program.

Patients who were included in TrP.A and TrP.B underwent a TR program using OS platforms for 8 consecutive weeks.

OS platforms used are: Zoom, Skype, Google Teams, WhatsApp. The patient was given the opportunity to choose the operating system to use based on their knowledge, computer skills and ease of use to facilitate the management of the session.

Patients in TrP.A and TrP.B had to perform at home a tailored exercise program 4 times/week for 45-60 minutes.

Twice a week, the activity was performed with physiotherapist through OSp. A specific exercise program for the parkinsonian patients was structured in relation to the individual residual motor skills based on the FITT - frequency/intensity/type/time - protocol. Both programs, A and B, include multiple exercise: aerobic activities, mobility and stretching exercises for upper and lower limbs, global muscle strengthening, balance & motor coordination training, start and stop exercises and walking training.

The exercises in program A were more complex and showed a higher intensity, while those in program B were simpler, safer and at lower intensity.

Subjects included in TmP.C participated in an 8-weeks program. A video-call was scheduled once a week to monitor the patient's clinical condition without any exercise program.

The target of this study was to have at least 90% of participants completing the program. To complete the program every single patient had to complete at least 80% of the prescribed TR sessions.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
33 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Parkinson Disease Telerehabilitation Program (PDTR): a Home-motor Program for Parkinson's Disease With Open-source Platforms. A Pilot Study.
Actual Study Start Date :
Feb 1, 2021
Actual Primary Completion Date :
Feb 28, 2022
Actual Study Completion Date :
Feb 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Telerehabilitation with OS platforms

Patients with Parkinson's Disease were divided into three subgruops based on their residual motor skills.

Other: Telerehabilitation with open source platforms
Telerehabilitation with opensource platforms. Patients enrolled were dived into three groups based on their score in SPPB. Each group corresponded to a Program (Pr): • Pr. A is for patients with capable motor skills, Pr. B is for patients with reduced motor skills, • Pr. C is for patients who didn't show having sufficient motor skills to support a TR program. Patients who were included in TrP.A and TrP.B underwent a TR program using OS platforms for 8 consecutive weeks. A specific exercise program for the parkinsonian patients was structured in relation to the individual residual motor skills based on the FITT - frequency/intensity/type/time - protocol. Twice a week, the activity was performed with the support of a physiotherapist through OS TR platform. Subjects included in TmP.C participated in an 8-weeks program. A video-call was scheduled once a week to monitor the patient's clinical condition without any exercise program.

Outcome Measures

Primary Outcome Measures

  1. The opportunity of the usage TR in PD patients by using free open-source platforms [1 year]

    90% of participants completing the program. To complete the program every single patient had to complete at least 80% of the prescribed TR sessions

Secondary Outcome Measures

  1. Patient's satisfaction [1 year]

    Administration of a specific questionnaire to evaluate the patient's satisfaction with TR treatment program with free open-source platforms

  2. Patient's agreement [1 year]

    Administration of a specific questionnaire to evaluate the patient's agreement with TR treatment program with free open-source systems

  3. Maintenance of clinical outcomes - Walking speed [1 year]

    Walking speed using 10 Meter Walking Test (10 MWT) rated in seconds. Comparison between T0 and T1 in the groups A and B. A descriptive analysis of the results was then conducted.

  4. Maintenance of clinical outcomes - Balance [1 year]

    Balance using MiniBEST Test (values: 0 minimum - 28 maximum). Comparison between T0 and T1 in the groups A and B. A descriptive analysis of the results was then conducted.

  5. Maintenance of clinical outcomes - Risk of falling [1 year]

    Risk of falling using the Time Up and Go (TUG Test) rated in seconds. Comparison between T0 and T1 in the groups A and B. A descriptive analysis of the results was then conducted.

  6. Perceived level of quality of life [1 years]

    Evaluation of the level of perceived quality of life using the the Parkinson's Disease Questionnaire (short version)(PDQ-8), (values: 0 minimum - 32 maximum. The summed scor is then divided by total possible score an given as a percentage score out of 100). Comparison between T0 and T1 in the groups A and B.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Hoehn & Yahr (H&Y) score between 1 and 3;

  • being on drug treatment stabilized with L-Dopa or dopamine agonists;

  • being able to walk independently (with or without help)

  • having adequate computer knowledge, be able to use online communication platforms and to undertake a continuous 8-weeks program.

Exclusion Criteria:
  • Montreal Cognitive Assessment screening test score below 17.54

  • having unpredictable motor fluctuations or non-pharmacologically controlled dyskinesias

  • having neurological pathologies superimposed on PD; or cognitive, sensory, psychiatric alterations such as to make it impossible to understand and execute the exercises; or musculoskeletal and cardiopulmonary diseases that compromise mild physical activity.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ics Maugeri Pavia PV Italy 27100

Sponsors and Collaborators

  • Istituti Clinici Scientifici Maugeri SpA

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chiara Vellata, Physiotherapy, Istituti Clinici Scientifici Maugeri SpA
ClinicalTrials.gov Identifier:
NCT05762562
Other Study ID Numbers:
  • prot. 2486 CE, 06/10/2020
First Posted:
Mar 9, 2023
Last Update Posted:
Mar 9, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chiara Vellata, Physiotherapy, Istituti Clinici Scientifici Maugeri SpA
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2023